Enzo Biochem

Enzo Biochem is a leading life sciences and biotechnology company dedicated to developing research tools, diagnostic methods, and therapeutic solutions by harnessing genetic processes, while also providing reference laboratory services to the medical community. Founded in 1976, Enzo Biochem focuses on the development of technologies in the fields of gene regulation and gene modification. Many of the company’s technologies are applicable to the biomedical and pharmaceutical research markets, and we further leverage these as platforms to enter the clinical diagnostics market. Today, Enzo’s technologies and products are recognized globally as key tools for non-radioactive gene labeling among researchers. Additionally, Enzo's work in genetic analysis has led to the development of numerous significant therapeutic candidates for treating virus- and immunology-based diseases, some of which are in various stages of human clinical trials. Through extensive R&D activities, we have established a robust patent portfolio, including numerous pioneering patents and applications related to our core technologies.Enzo Biochem’s business operations are conducted through its three wholly-owned subsidiaries: Enzo Life Sciences, Enzo Therapeutics, and Enzo Clinical Labs. These operations include the research, development, manufacturing, and marketing of biomedical research products and tools through Enzo Life Sciences, the research and development of therapeutic products through Enzo Therapeutics, and the operation of regional clinical reference laboratories through Enzo Clinical Labs.